ANALYSING SCHIZOPHRENIA RISK VARIANTS IN NRXN1 USING FUNCTIONAL AND MATURE NEURONAL CULTURES FROM PATIENT-DERIVED IPS CELLS

被引:0
|
作者
Jung, Matthias [1 ]
Majer, Annika [1 ]
Reinsch, Jessica [1 ]
Schiller, Jovita [1 ]
Hartmann, Annette [1 ]
Konte, Bettina [1 ]
Giegling, Ina [1 ]
Rujescu, Dan [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Halle, Germany
关键词
D O I
10.1016/j.euroneuro.2018.08.494
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
SU130
引用
收藏
页码:1335 / 1336
页数:2
相关论文
共 14 条
  • [1] Analysing schizophrenia risk variants in NRXN1 using functional and mature neuronal cultures from patient-derived iPS cells
    Jung, M.
    Pfeifer, J.
    Majer, A.
    Reinsch, J.
    Flegel, N.
    Puls, A.
    Hartmann, A.
    Konte, B.
    Giegling, I
    Rujescu, D.
    PHARMACOPSYCHIATRY, 2020, 53 (02) : 86 - 86
  • [2] Analysing early neuronal differentiation in patient-derived induced pluripotent stem cells (iPSC) with altered expression of NRXN1
    Polit, L. Dutan
    Adhya, D.
    Gatford, N.
    Srivastava, D. P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S481 - S481
  • [3] ANALYSIS OF NRXN1 EXPRESSION DURING EARLY NEURONAL DIFFERENTIATION IN PATIENT-DERIVED INDUCED PLURIPOTENT STEM CELLS (IPSC) WITH ALTERED EXPRESSION OF NRXN1
    Polit, Lucia Dutan
    Adhya, Deep
    Gatford, Nick
    Nagy, Roland
    Srivastava, Deepak
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 51 : E198 - E198
  • [4] Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells
    Shin-ichiro Sekine
    Masayuki Kaneko
    Masaki Tanaka
    Yuhei Ninomiya
    Hisaka Kurita
    Masatoshi Inden
    Megumi Yamada
    Yuichi Hayashi
    Takashi Inuzuka
    Jun Mitsui
    Hiroyuki Ishiura
    Atsushi Iwata
    Hiroto Fujigasaki
    Hisamitsu Tamaki
    Ryusei Tamaki
    Shinsuke Kito
    Yoshiharu Taguchi
    Kortaro Tanaka
    Naoki Atsuta
    Gen Sobue
    Takayuki Kondo
    Haruhisa Inoue
    Shoji Tsuji
    Isao Hozumi
    Scientific Reports, 9
  • [5] Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells
    Sekine, Shin-ichiro
    Kaneko, Masayuki
    Tanaka, Masaki
    Ninomiya, Yuhei
    Kurita, Hisaka
    Inden, Masatoshi
    Yamada, Megumi
    Hayashi, Yuichi
    Inuzuka, Takashi
    Mitsui, Jun
    Ishiura, Hiroyuki
    Iwata, Atsushi
    Fujigasaki, Hiroto
    Tamaki, Hisamitsu
    Tamak, Ryusei
    Kito, Shinsuke
    Taguchi, Yoshiharu
    Tanaka, Kortaro
    Tsuta, Naokia
    Sobue, Gen
    Kondo, Takayuki
    Inoue, Haruhisa
    Tsuji, Shoji
    Hozumi, Isao
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [6] ANALYSING ALZHEIMER'S DISEASE (AD) RISK VARIANTS IN CD33 AND TREM2 USING MICROGLIA-LIKE CELLS FROM PATIENT-DERIVED IPS CELLS
    Ehrhardt, Toni
    Jung, Matthias
    Bezold, Veronika
    Bork, Kaya
    Hartmann, Carla
    Giegling, Ina
    Rujescu, Dan
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1129 - 1130
  • [7] DRUG DISCOVERY FOR CFTR PTC VARIANTS: FROM HIGH THROUGHPUT SCREENING TO COMPOUND TESTING IN PATIENT-DERIVED IPS CELLS
    Liang, F.
    Wong, E.
    Jordan, N. J.
    Simpkinson, M.
    Shang, H.
    Fitzpatrick, L.
    Zahid, Y.
    Mahoney, J. E.
    Mense, M.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S233 - S233
  • [8] Bi-allelic NRXN1α deletion in microglia derived from iPSC of an autistic patient increases interleukin-6 production and impairs supporting function on neuronal networking
    Bose, Raj
    Posada-Perez, Mercedes
    Karvela, Eleni
    Skandik, Martin
    Keane, Lily
    Falk, Anna
    Spulber, Stefan
    Joseph, Bertrand
    Ceccatelli, Sandra
    BRAIN BEHAVIOR AND IMMUNITY, 2025, 123 : 28 - 42
  • [9] Functional Evaluation of Human Bioengineered Cardiac Tissue Using iPS Cells Derived from a Patient with Lamin Variant Dilated Cardiomyopathy
    Miura, Koichiro
    Matsuura, Katsuhisa
    Itoyama, Yu Yamasaki
    Sasaki, Daisuke
    Takada, Takuma
    Furutani, Yoshiyuki
    Hayama, Emiko
    Ito, Masamichi
    Nomura, Seitaro
    Morita, Hiroyuki
    Toyoda, Masashi
    Umezawa, Akihiro
    Onoue, Kenji
    Saito, Yoshihiko
    Aburatani, Hiroyuki
    Nakanishi, Toshio
    Hagiwara, Nobuhisa
    Komuro, Issei
    Shimizu, Tatsuya
    INTERNATIONAL HEART JOURNAL, 2022, 63 (02) : 338 - 346
  • [10] Patient-derived iPS cells for unveiling the molecular pathology of Pelizaeus-Merzbacher disease: a commentary on ‘Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus–Merzbacher disease patient with a partial PLP1 duplication’
    Ken Inoue
    Journal of Human Genetics, 2012, 57 : 553 - 554